1,515
Participants
Start Date
July 16, 2018
Primary Completion Date
January 20, 2020
Study Completion Date
January 20, 2020
V114
15-valent pneumococcal conjugate vaccine with serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F (2 mcg each), serotype 6B (4 mcg) and Merck Aluminum Phosphate Adjuvant (125 mcg) in each 0.5 mL dose
Prevnar 13™
13-valent pneumococcal conjugate vaccine with serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 23F (2.2 mcg) and 6B (4.4 mcg), and aluminum phosphate adjuvant (125 mcg aluminum) in each 0.5 ml dose
PNEUMOVAX™23
23-valent pneumococcal polysaccharide vaccine with serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F (25 mcg each) in each 0.5 mL dose
Auckland Clinical Studies Limited ( Site 0189), Auckland
Optimal Clinical Trials ( Site 0182), Auckland
Holdsworth House Medical Practice ( Site 0170), Sydney
Paratus Clinical Pty Ltd - Blacktown Clinic ( Site 0174), Blacktown
Paratus Clinical Kanwal ( Site 0172), Kanwal
Nepean Hospital ( Site 0176), Kingswood
Lakeland Clinical Trials ( Site 0181), Rotorua
Emeritus Research Pty Ltd ( Site 0173), Camberwell
Bay of Plenty Clinical School ( Site 0186), Tauranga
Core Research Group Pty limited ( Site 0175), Brisbane
P3 Research Ltd - Wellington ( Site 0184), Wellington
Christchurch Heart Institute ( Site 0280), Christchurch
Southern Clinical Trials Ltd ( Site 0180), Christchurch
Mid Hudson Medical Research ( Site 0022), New Windsor
Corning Center For Clinical Research ( Site 0036), Corning
Lehigh Valley Health Network ( Site 0040), Allentown
University of Pennsylvania ( Site 0030), Philadelphia
Wake Research Associates, LLC ( Site 0016), Raleigh
Mountain View Clinical Research ( Site 0007), Greer
Emory University School of Medicine at Grady Hospital ( Site 0027), Atlanta
Indago Research & Health Center, Inc ( Site 0054), Hialeah
Top Medical Research, Inc ( Site 0033), Cutler Bay
Triple O Research Institute, P.A. ( Site 0026), West Palm Beach
Renstar Medical Research ( Site 0008), Ocala
Holston Medical Group ( Site 0025), Kingsport
Reid Physician Associates ( Site 0055), Richmond
Marshfield Clinic ( Site 0013), Marshfield
Gundersen Health System ( Site 0021), La Crosse
Evanston Premier Healthcare & Research, LLC. ( Site 0012), Evanston
Pharmakon Inc ( Site 0049), Evergreen Park
The Center for Pharmaceutical Research PC ( Site 0050), Kansas City
Village Health Partners ( Site 0006), Plano
Texas Institute Of Cardiology ( Site 0048), McKinney
AIM Trials ( Site 0060), Fort Worth
Private Practice Leadership, LLC ( Site 0051), Houston
Texas Center For Drug Development ( Site 0041), Houston
Kootenai Health ( Site 0042), Coeur d'Alene
Copperview Medical Center ( Site 0038), South Jordan
Central Phoenix Medical Clinic, LLC ( Site 0031), Phoenix
Pulmonary Associates, PA ( Site 0043), Glendale
Whiteriver Center for American Indian Health ( Site 0005), Whiteriver
Chinle Comprehensive Health Care Facility ( Site 0001), Chinle
Fort Defiance Center for American Indian Health ( Site 0002), Fort Defiance
Gallup Center for American Indian Health ( Site 0003), Gallup
Shiprock Center for American Indian Health ( Site 0004), Shiprock
Clinical Research Consortium ( Site 0053), Las Vegas
Inland Empire Clinical Trials, LLC ( Site 0052), Rialto
Pulmonary & Sleep Research ( Site 0046), Spokane Valley
Smolensk State Medical University ( Site 0246), Smolensk
Saratov State Medical University n.a. V.I.Razumovskiy ( Site 0144), Saratov
Republican Clinical Hospital of Infectious Diseases n. a. A.F.Agafonov ( Site 0249), Kazan'
Hospital Dr. Hernan Henriquez Aravena ( Site 0105), Temuco
Clinica Arauco Salud ( Site 0100), Santiago
Centro de Investigacion Clinica UC CICUC ( Site 0104), Santiago
CECIM ( Site 0101), Santiago
CESFAM Esmeralda ( Site 0102), Santiago
Internal Medicine Associates [Bridgeton, NJ] ( Site 0015), Bridgeton
University of Texas Medical Branch at Galveston ( Site 0034), Galveston
Timber Lane Allergy & Asthma Research, LLC ( Site 0044), South Burlington
The Liver and Intestinal Research Centre (LAIR) ( Site 0302), Vancouver
GA Research Associates, Ltd/Ltee ( Site 0303), Moncton
Colchester Research Group ( Site 0094), Truro
Hamilton Medical Research Group ( Site 0092), Hamilton
SKDS Research Inc. ( Site 0099), Newmarket
Omnispec Recherche Clinique Inc ( Site 0093), Mirabel
Dynamik Research ( Site 0095), Pointe-Claire
Diex Recherche Quebec Inc ( Site 0091), Québec
Q & T Research Sherbrooke Inc. ( Site 0097), Sherbrooke
Southern Clinical Trials - Waitemata ( Site 0183), Auckland
WSOZ im.T.Browicza w Bydgoszczy ( Site 0317), Bydgoszcz
Centrum Medyczne Pratia Bydgoszcz ( Site 0139), Bydgoszcz
Synexus Polska Sp. z o.o. ( Site 0238), Gdansk
Specjalistyczny osrodek .All-Med. Grazyna Pulka ( Site 0233), Krakow
ID Clinic ( Site 0235), Mysłowice
Centrum Medyczne Ogrodowa Sp. Z o.o. ( Site 0319), Skierniewice
Niepubliczny Zaklad Opieki Zdrowotnej ( Site 0314), Sopot
Wroclawskie Centrum Zdrowia SP ZOZ ( Site 0236), Wroclaw
Synexus Polska Sp. z o.o. oddział we Wrocławiu ( Site 0234), Wroclaw
Merck Sharp & Dohme LLC
INDUSTRY